Physician Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Physician Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.84K	Buy	17 +9	+113%	+$2.65K	﹤0.01%	1115
2026 Q1	$2.38K	Sell	8 -6	-43%	-$1.94K	﹤0.01%	1275
2025 Q4	$4.25K	Buy	14 +3	+27%	+$982	﹤0.01%	1022
2025 Q3	$3.75K	Buy	11 +3	+38%	+$911	﹤0.01%	1003
2025 Q2	$1.94K	Buy	8 +5	+167%	+$1.23K	﹤0.01%	1060
2025 Q1	$817	Buy	3 +2	+200%	+$468	﹤0.01%	1222
2024 Q4	$185	Buy	+1	New	+$204	﹤0.01%	1120

Other funds holding ONC

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

WAS

WESPAC Advisors SoCal Pasadena, California $560M AUM 37.11% 1-Year Est. Return

PFA

Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return

CST

Charles Schwab Trust Henderson, Nevada $1.79B AUM 17.47% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

SOAM

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

JGGDR

JGP Global Gestao de Recursos Rio De Janeiro, Brazil $45.3M AUM 42.75% 1-Year Est. Return

Physician Wealth Advisors's ONC Position: Q2 2026 in Review

Physician Wealth Advisors increased its BeOne Medicines Ltd (ONC) stake by 113% in Q2 2026, buying an estimated $2.65K and bringing the position to 17 shares worth $4.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

Physician Wealth Advisors first reported a position in ONC in Q4 2024 and has held it in 7 quarters since. 36 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Physician Wealth Advisors held 17 shares of BeOne Medicines Ltd worth $4.84K as of Q2 2026.
Physician Wealth Advisors bought 9 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.65K.
BeOne Medicines Ltd made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1115 holding.
Physician Wealth Advisors first reported a position in BeOne Medicines Ltd in Q4 2024 and has held it in 7 quarters since.
36 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.